There have been 50 recent insider transactions recorded for Monte Rosa Therapeutics, Inc. (GLUE), including 29 buys and 20 sells. Total insider buying was valued at $8.8M and total insider selling at $11.95M.
Notable insiders with recent activity include Dunn Edmund, Warmuth Markus, Janku Filip. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — GLUE
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-04 |
Dunn Edmund |
Principal Accounting Officer |
Informative Sell |
139 |
$17.96 |
$2.5K |
22,554 |
| 2026-03-02 |
Dunn Edmund |
Principal Accounting Officer |
Option Exercise (Sell) |
536 |
$13.41 |
$7.19K |
- |
| 2026-03-02 |
Warmuth Markus |
President & CEO |
Informative Sell |
5,466 |
$17.92 |
$97.97K |
613,471 |
| 2026-02-27 |
Dunn Edmund |
Principal Accounting Officer |
Option Exercise (Sell) |
25,164 |
$13.41 |
$337.45K |
536 |
| 2026-02-23 |
Janku Filip |
Chief Medical Officer |
Informative Sell |
9,189 |
$19.50 |
$179.16K |
65,837 |
| 2026-01-07 |
Warmuth Markus |
President & CEO |
Informative Sell |
309 |
$24.57 |
$7.59K |
618,937 |
| 2026-01-05 |
Warmuth Markus |
President & CEO |
Informative Sell |
10,135 |
$15.17 |
$153.75K |
624,403 |
| 2026-01-05 |
Townson Sharon |
Chief Scientific Officer |
Informative Sell |
3,155 |
$15.17 |
$47.86K |
67,845 |
| 2026-01-05 |
Janku Filip |
Chief Medical Officer |
Informative Sell |
3,155 |
$15.17 |
$47.86K |
75,026 |
| 2026-01-05 |
Nickson Philip |
Chief Business & Legal Officer |
Informative Sell |
3,155 |
$15.17 |
$47.86K |
60,845 |
| 2026-01-05 |
Dunn Edmund |
Principal Accounting Officer |
Informative Sell |
1,039 |
$15.17 |
$15.76K |
22,693 |
| 2026-01-05 |
Champoux Jennifer |
Chief Operating Officer |
Informative Sell |
2,629 |
$15.17 |
$39.88K |
62,371 |
| 2026-01-02 |
Warmuth Markus |
President & CEO |
RSU Award |
406,000 |
$15.31 |
$6.22M |
406,000 |
| 2026-01-02 |
Townson Sharon |
Chief Scientific Officer |
RSU Award |
35,000 |
- |
- |
71,000 |
| 2026-01-02 |
Janku Filip |
Chief Medical Officer |
RSU Award |
31,000 |
- |
- |
78,181 |
| 2026-01-02 |
Nickson Philip |
Chief Business & Legal Officer |
RSU Award |
28,000 |
- |
- |
64,000 |
| 2026-01-02 |
Champoux Jennifer |
Chief Operating Officer |
RSU Award |
35,000 |
- |
- |
65,000 |
| 2025-06-13 |
Schiff Andrew N |
Director |
RSU Award |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Behbahani Ali |
10 Percent Owner |
RSU Award |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Manning Anthony M. |
Director |
RSU Award |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Siu Christine |
Director |
RSU Award |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Blackwell Kimberly |
Director |
RSU Award |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Skvarka Jan |
Director |
RSU Award |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Hughes Eric A |
Director |
RSU Award |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-03 |
Dunn Edmund |
Principal Accounting Officer |
Informative Sell |
2,062 |
$4.45 |
$9.17K |
23,732 |
| 2025-03-24 |
Leo Chandra P. |
Director |
Informative Buy |
10,000 |
$5.84 |
$58.38K |
10,000 |
| 2025-01-02 |
Warmuth Markus |
President & CEO |
RSU Award |
128,000 |
- |
- |
544,538 |
| 2025-01-02 |
Townson Sharon |
Chief Scientific Officer |
RSU Award |
36,000 |
- |
- |
36,000 |
| 2025-01-02 |
Janku Filip |
Chief Medical Officer |
RSU Award |
36,000 |
- |
- |
45,189 |
| 2025-01-02 |
Nickson Philip |
Chief Business & Legal Officer |
RSU Award |
36,000 |
- |
- |
36,000 |
| 2025-01-02 |
Dunn Edmund |
Principal Accounting Officer |
RSU Award |
11,850 |
- |
- |
25,794 |
| 2025-01-02 |
Champoux Jennifer |
Chief Operating Officer |
RSU Award |
30,000 |
- |
- |
30,000 |
| 2024-12-11 |
Hughes Eric A |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-12-11 |
Hughes Eric A |
Director |
RSU Award |
44,200 |
$8.51 |
$376.14K |
44,200 |
| 2024-10-29 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
Informative Sell |
15,600 |
$9.41 |
$146.79K |
1,573,453 |
| 2024-10-28 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
Other (Sell) |
5,454 |
- |
- |
- |
| 2024-09-20 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
Informative Sell |
1,132,566 |
$6.53 |
$7.4M |
5,099,336 |
| 2024-09-13 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
Informative Sell |
9,269 |
$6.16 |
$57.1K |
6,231,902 |
| 2024-09-13 |
Janku Filip |
Chief Medical Officer |
RSU Award |
30,000 |
$7.56 |
$226.8K |
30,000 |
| 2024-09-12 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
Informative Sell |
16,047 |
$6.00 |
$96.31K |
6,241,171 |
| 2024-09-11 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
Informative Sell |
541,897 |
$6.00 |
$3.25M |
6,257,218 |
| 2024-07-05 |
Dunn Edmund |
Principal Accounting Officer |
Informative Sell |
1,610 |
$3.83 |
$6.17K |
13,944 |
| 2024-06-12 |
Schiff Andrew N |
Director |
RSU Award |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Behbahani Ali |
10 Percent Owner |
RSU Award |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Manning Anthony M. |
Director |
RSU Award |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Siu Christine |
Director |
RSU Award |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Blackwell Kimberly |
Director |
RSU Award |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Skvarka Jan |
Director |
RSU Award |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-03 |
Townson Sharon |
Chief Scientific Officer |
RSU Award |
40,000 |
$3.98 |
$159.2K |
40,000 |
| 2024-06-03 |
Nickson Philip |
Chief Business & Legal Officer |
RSU Award |
40,000 |
$3.98 |
$159.2K |
40,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
